Clinical Trial Update: Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC) [Phase 2]

View source ↗

Summary

A multicenter Phase II randomized study evaluating adebrelimab in combination with chemotherapy and concurrent low-dose radiotherapy for extensive-stage small c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Sichuan University | Conditions: Small Cell Lung Cancer Extensive Stage | Phase 2 | Status: RECRUITING